Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4623745012 | Daclatasvir dihydrochloride (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4623746013 | Daclatasvir dihydrochloride | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Daclatasvir dihydrochloride (substance) | Is a | Hepatitis C virus protein NS5A inhibitor | true | Inferred relationship | Some | ||
| Daclatasvir dihydrochloride (substance) | Has disposition (attribute) | Hepatitis C virus protein NS5A inhibitor (disposition) | true | Inferred relationship | Some | ||
| Daclatasvir dihydrochloride (substance) | Is modification of (attribute) | Daclatasvir (substance) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely daclatasvir (as daclatasvir dihydrochloride) 60 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | True | Daclatasvir dihydrochloride (substance) | Inferred relationship | Some | 1 |
| Product containing precisely daclatasvir (as daclatasvir dihydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | True | Daclatasvir dihydrochloride (substance) | Inferred relationship | Some | 1 |
| Product containing precisely daclatasvir (as daclatasvir dihydrochloride) 90 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | True | Daclatasvir dihydrochloride (substance) | Inferred relationship | Some | 1 |
This concept is not in any reference sets
FHIR